Skip to main navigation
Galectin Therapeutics Logo
  • Blog
  • What We Do
    • Galectin Proteins
    • Develop Proprietary Compounds
    • Discovery Programs
    • Intellectual Property
  • Our Pipeline
    • Pipeline Overview
    • Development Programs
  • About
    • About Us
    • Leadership
    • Board of Directors
    • Careers
  • Investor Relations
    • Overview
    • Press Releases + News
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • FAQs
    • Email Alert Subscription
  • Learn More
    • About Belapectin
    • About Galectin-3
    • About the NAVIGATE Study
    • Resources
    • Video Library
    • Publications
    • News
  • Contact Us
  • What We Do
    • Galectin Proteins
    • Develop Proprietary Compounds
    • Discovery Programs
    • Intellectual Property
  • Our Pipeline
    • Pipeline Overview
    • Development Programs
  • About
    • About Us
    • Leadership
    • Board of Directors
    • Careers
  • Investor Relations
    • Overview
    • Press Releases + News
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • FAQs
    • Email Alert Subscription
  • Learn More
    • About Belapectin
    • About Galectin-3
    • About the NAVIGATE Study
    • Resources
    • Video Library
    • Publications
    • News
  • Contact Us
Committee Composition

Investor Relations

  • Overview
  • Press Releases + News
  • Events & Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • Stock Information
    • Analyst Coverage
  • FAQs
  • Email Alert Subscription

Committee Composition

Independent Director Audit Committee Compensation Committee Nominating and Governance Committee
Richard A. Zordani Independent Director Audit Committee
Elissa J. Schwartz, Ph.D. Independent Director Nominating and Governance Committee
Gilbert F. Amelio, Ph.D. Independent Director Compensation Committee Nominating and Governance Committee
Kevin D. Freeman, CFA Independent Director Audit Committee Compensation Committee Nominating and Governance Committee
Gilbert S. Omenn, M.D., Ph.D Independent Director Compensation Committee
Kary Eldred Independent Director Audit Committee
Benjamin S. Carson, Sr., M.D. Independent Director Nominating and Governance Committee
= Independent Director = Chairperson = Member
Galectin Therapeutics Logo - Footer

© 2026 Galectin Therapeutics Inc. – All Rights Reserved

  • Compassionate Use Policy
  • Privacy Policy
  • Terms of Use
  • Sitemap

Disclaimer: This site may contain forward-looking information.